THC Therapeutics, Inc. Quarterly Nonoperating Income (Expense) in USD from Q3 2021 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
THC Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q3 2021 to Q1 2023.
  • THC Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending April 30, 2023 was $152K.
  • THC Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending April 30, 2023 was $970K.
  • THC Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was $227K.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $970K $152K +$661K Feb 1, 2023 Apr 30, 2023 10-Q 2024-01-09
Q4 2022 $309K $1.96M +$1.84M +1595% Nov 1, 2022 Jan 31, 2023 10-Q 2024-01-08
Q3 2022 -$1.53M -$2.03M -$1.76M -665% Aug 1, 2022 Oct 31, 2022 10-Q 2022-12-22
Q2 2022 $227K $885K May 1, 2022 Jul 31, 2022 10-K 2022-11-25
Q1 2022 -$509K Feb 1, 2022 Apr 30, 2022 10-Q 2024-01-09
Q4 2021 $116K Nov 1, 2021 Jan 31, 2022 10-Q 2024-01-08
Q3 2021 -$265K Aug 1, 2021 Oct 31, 2021 10-Q 2022-12-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.